| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/27/2007 | CA2655890A1 Method of determining 1,5-anhydroglucitol, and reagent composition for determining 1,5-anhydroglucitol |
| 12/27/2007 | CA2655582A1 Method and kit for the detection of heparin-dependent antibodies and the diagnosis of immune or autoimmune pathologies potentiated by heparin such as heparin-induced thrombocytopenia |
| 12/27/2007 | CA2655497A1 Dpyd gene variants and use thereof |
| 12/27/2007 | CA2655458A1 Methods and compositions for obtaining amplifiable nucleic acids from tissues, cells, or viruses exposed to transport media |
| 12/27/2007 | CA2655174A1 A method of tracing movement of a liquid |
| 12/27/2007 | CA2654499A1 Capillary flow control in a flow channel |
| 12/27/2007 | CA2654458A1 Regulation of protein activity by reversible acetylation |
| 12/27/2007 | CA2654266A1 Methylation markers for early detection and prognosis of colon cancers |
| 12/26/2007 | EP1870478A1 Biosensor element and method for manufacturing the same |
| 12/26/2007 | EP1870477A1 Method of measuring enzyme activity and method of evaluating compound |
| 12/26/2007 | EP1870469A1 Novel altered gene from rice anthranilic acid synthase gene oasa2 and use thereof |
| 12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
| 12/26/2007 | EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870464A2 Methods and compositions for inhibiting neoplastic cell growth |
| 12/26/2007 | EP1870461A2 Method for identifying within a mammal a DNA encoding physiologically active polypeptide |
| 12/26/2007 | EP1870455A1 Method for distinguishing mesenchymal stem cell using molecular marker and use thereof |
| 12/26/2007 | EP1869961A2 Automated seed sampler and methods of sampling, testing and bulking seeds |
| 12/26/2007 | EP1869458A1 Nutritional compositions for modulating vitamin c bio-availability |
| 12/26/2007 | EP1869455A2 Method and apparatus for detection of abnormal traces during electrochemical analyte detection |
| 12/26/2007 | EP1869454A2 Analyte determination method and analyte meter |
| 12/26/2007 | EP1869440A2 Method for determination of analyte concentrations and related apparatus |
| 12/26/2007 | EP1869226A2 Viral nucleoprotein detection using an ion channel switch biosensor |
| 12/26/2007 | EP1869225A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 12/26/2007 | EP1869224A2 Methylation markers for diagnosis and treatment of cancers |
| 12/26/2007 | EP1869223A1 5 /3 ratioing procedure for detection of gene rearrangements |
| 12/26/2007 | EP1869222A2 Methylation markers for diagnosis and treatment of cancers |
| 12/26/2007 | EP1869221A2 Flow-cytometric heteroduplex analysis for detection of genetic alterations |
| 12/26/2007 | EP1869220A2 Epidermal growth factor receptor gene copy number |
| 12/26/2007 | EP1869219A2 Multiplex assay systems |
| 12/26/2007 | EP1869218A2 Nucleic acid detection |
| 12/26/2007 | EP1869217A2 Methods, compositions, and kits for detection of micro rna |
| 12/26/2007 | EP1869216A2 Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds |
| 12/26/2007 | EP1869215A2 Improved bisulfite conversion of dna |
| 12/26/2007 | EP1869214A2 Biomarkers for pharmacogenetic diagnosis of type 2 diabetes |
| 12/26/2007 | EP1869213A2 Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
| 12/26/2007 | EP1869212A2 Use of id4 for diagnosis and treatment of cancer |
| 12/26/2007 | EP1869211A1 Multiple snp for diagnosing colorectal cancer, microarray and kit comprising the same, and method of diagnosing colorectal cancer using the same |
| 12/26/2007 | EP1869210A2 Peptide stabilizer compounds and screening method |
| 12/26/2007 | EP1869209A2 Traceability of cellular cycle anomalies targeting oncology and neurodegeneration |
| 12/26/2007 | EP1869208A1 Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues |
| 12/26/2007 | EP1869207A1 METHOD FOR ASSESSING THE PRESDISPOSITION AND/OR SUSCEPTIBILITY TO COPD BY ANALYSING FGF-BPl |
| 12/26/2007 | EP1869205A2 Assays for determining compounds which modulate tram phosphorylation |
| 12/26/2007 | EP1869204A1 A method for the detection of atp in a sample with the aid of luminescence and a computer programme for that purpose |
| 12/26/2007 | EP1869203A1 Oxidizable species as an internal reference in control solutions for biosensors |
| 12/26/2007 | EP1869187A2 Elite event a2704-12 and methods and kits for identifying such event in biological samples |
| 12/26/2007 | EP1869180A2 Compositions for use in identification of adventitious viruses |
| 12/26/2007 | EP1869179A2 Method for treating a sample that contains biomolecules |
| 12/26/2007 | EP1869174A2 Lyase enzymes, nucleic acids encoding them and methods for making and using them |
| 12/26/2007 | EP1869173A2 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
| 12/26/2007 | EP1869165A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 12/26/2007 | EP1869157A1 Flexible culture medium bag containing nutrient concentrate |
| 12/26/2007 | EP1869082A2 Coagulation and fibrinolytic cascades modulator |
| 12/26/2007 | EP1869061A2 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array |
| 12/26/2007 | EP1869060A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 12/26/2007 | EP1868638A2 Cross-beta structure on microbial organisms |
| 12/26/2007 | EP1868426A2 Corn event 3272 and methods of detection thereof |
| 12/26/2007 | EP1761649B1 Human autism predisposition gene encoding a transcription factor and uses thereof |
| 12/26/2007 | EP1706513A4 Human immunodeficiency virus entry inhibitor assay |
| 12/26/2007 | EP1694866A4 Gene expression profiles and methods of use |
| 12/26/2007 | EP1692281B1 Identification of a jak2 mutation in polycythemia vera |
| 12/26/2007 | EP1629122A4 Electrocatalytic nucleic acid hybridization detection |
| 12/26/2007 | EP1623010A4 Preservation of rna in a biological sample |
| 12/26/2007 | EP1581658A4 Status determination |
| 12/26/2007 | EP1576177A4 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance |
| 12/26/2007 | EP1575420A4 Prostate cancer biomarkers |
| 12/26/2007 | EP1567045A4 Methods for diagnosing the presence or stage of cancer |
| 12/26/2007 | EP1520049B1 Nucleic acid amplification method |
| 12/26/2007 | EP1516174B1 Method and device for high sensitivity detection of the presence of dna and other probes |
| 12/26/2007 | EP1506310A4 Biosensor |
| 12/26/2007 | EP1478770B1 Screening method for orthopoxvirus antivirals |
| 12/26/2007 | EP1419381B1 Lytic reagent composition for determination of nucleated red blood cells |
| 12/26/2007 | EP1294938B1 Cell-binding nucleic acid molecules (aptamers) |
| 12/26/2007 | EP1287024B1 Virulence genes, proteins, and their use |
| 12/26/2007 | EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 12/26/2007 | EP1218532B1 Method for monitoring an analyte using an electrochemical Biosensor which can be turned off by applying an electrical potential |
| 12/26/2007 | EP1185699B1 Microarray-based subtractive hybridization |
| 12/26/2007 | EP1121461B1 Fluorescent probes for chromosomal painting |
| 12/26/2007 | EP1005571B1 In-vitro method for providing templates for DNA sequencing |
| 12/26/2007 | EP1005566B8 Regeneration of biosensors |
| 12/26/2007 | EP0904406B1 Heteroduplex tracking assay (hta) for genotyping hcv |
| 12/26/2007 | CN200996962Y Colpitis testing card |
| 12/26/2007 | CN200996953Y Apparatus for generating movable electric field force |
| 12/26/2007 | CN101094923A Method for detecting DNA point mutations (single nucleotide polymorphism (SNP) analysis) and associated arrangement |
| 12/26/2007 | CN101094682A Strain of lactobacillus acidophilus having analgesic properties in the gastrointestinal system |
| 12/26/2007 | CN101093226A System and method for distinguishing marker of secretion type protein |
| 12/26/2007 | CN101093222A Fluorescent probe in use for detecting glutathion inside cell, synthesis method and application |
| 12/26/2007 | CN101093221A Application of GADD45 ¿C beta protein and relevant cell factor in treating rheumatoid arthritis |
| 12/26/2007 | CN101093195A Kit for detecting susceptibility of coronary heart disease |
| 12/26/2007 | CN101093194A Kit for detecting susceptibility of hyperlipemia |
| 12/26/2007 | CN101092651A Kit and method for testing hypotype of virogene of hepatitis B and drug fast mutation |
| 12/26/2007 | CN101092650A Method for detecting gastric cancer by detecting VLDLR gene |
| 12/26/2007 | CN101092649A Method for diagnosing cancer using cancer-related deletion gene marker |
| 12/26/2007 | CN101092648A Kit for testing tiny gene loss of male Y chromosome, and testing method |
| 12/26/2007 | CN101092647A Nucleic acid film tape and kit for diagnosing alpha mediterranean anemia |
| 12/26/2007 | CN101092646A Method for diagnosing sporangium and egg capsule molecules of sarcocyst |
| 12/26/2007 | CN101092645A Novel method for diagnosing pathogens of sexually transmitted diseases |
| 12/26/2007 | CN101092644A Quick detecting gene mutation correlative to curative effect of non small-cell carcinoma of the lung |
| 12/26/2007 | CN101092643A Culture medium for asepsis test in medication of quinolone category, and application |
| 12/26/2007 | CN101092642A Bacteria count culture medium for limit test of microbe in medication of quinolone category, and application |